Skip to main content
FinSpry Logo
FinSpry
ATYR logo
ATYR
(NASDAQ)
aTyr Pharma, Inc.
$0.50-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

aTyr Pharma (ATYR) Stock Price & Financial Analysis

aTyr Pharma Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$0.49 - $0.51
52-Week High$6.50
52-Week Low$0.40
Open$0.49
Volume252.61K
Average Volume (3M)622.53K
Market Cap48.76M
Shares Outstanding98.04M
Price to Sales (P/S)256.62
Price to Book (P/B)0.84
EV/EBITDA-0.73
Revenue (TTM)190.00K
Net Income (TTM)-70.03M
Free Cash Flow (TTM)-59.30M
EPS (TTM)$-0.73
Profit Margin-36857.37%
Operating Margin-38573.68%
Return on Equity (ROE)-120.88%
Debt to Equity0.20
50-Day MA$0.53
200-Day MA$0.70
52-Week Change-91.14%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About aTyr Pharma

What is the current stock price for ATYR?

As of the latest trading session, ATYR stock trades at $0.50. The 52-week range is $0.40–$6.50, with a day range of $0.49–$0.51.

What is the P/E ratio for ATYR?

The P/E ratio (Price-to-Earnings) for ATYR is shown in the Key Statistics section. This valuation metric helps compare aTyr Pharma, Inc. to industry peers.

Does ATYR pay dividends?

aTyr Pharma does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ATYR?

Based on 2 analysts, the consensus for ATYR is Buy.

What is the market cap of ATYR?

aTyr Pharma's market capitalization is $48.8M, classifying it as a micro-cap company. aTyr Pharma operates in the Healthcare sector within the Biotechnology industry.